Clayton Dubilier & Rice
Clayton Dubilier & Rice is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Clayton Dubilier & Rice.
Clayton Dubilier & Rice is a company.
Key people at Clayton Dubilier & Rice.
Key people at Clayton Dubilier & Rice.
Clayton, Dubilier & Rice (CD&R) is a leading private equity firm founded on an operational approach to investing, partnering with management teams to build stronger businesses through operational improvements, strategic initiatives, and long-term value creation.[1][3][6] Its mission emphasizes trust, partnership, creativity, and operational excellence, targeting established middle-market companies primarily in North America and Europe across sectors like business services, consumer/retail, healthcare, industrials, technology, and financial services.[1][2][4] With approximately $30-66.9 billion invested in around 90 businesses, CD&R ranks among the world's top private equity firms (11th in PEI 300 as of June 2024) and focuses on sustainable growth rather than quick flips, distinguishing it from pure financial buyers.[1][2][6] While not primarily startup-focused, its investments in tech and healthcare (e.g., Zephyr AI, agilon health) indirectly support ecosystem growth by scaling innovative companies.[1]
CD&R traces its roots to 1976, when it began as a turnaround management firm under Clayton & Dubilier, founded by Martin H. Dubilier, Eugene Clayton, and Bill Welsh; Joseph L. Rice III joined in 1978, formalizing the name Clayton, Dubilier & Rice.[2][3] The founders believed combining financial acumen with operating expertise would drive superior decisions and business building, pioneering an "operational approach" to private equity that prioritized integrity and long-term performance.[3][5] Clayton and Welsh retired in 1985, Dubilier passed in 1991, and the firm rebranded fully in 1992; leadership transitioned with Joe Rice stepping down as chairman in 2012, succeeded by Don Gogel.[2] Over 45+ years, CD&R evolved from turnarounds to large-scale investments, navigating cycles with a consistent focus on operational value creation, as seen in deals like acquiring stakes in B&M Retail (2013), Core & Main (2017), and recent ones like Sealed Air (2024).[2][3][6]
CD&R rides the wave of operational transformation in tech-adjacent sectors like healthcare tech (agilon health, Mosaic Health, Zephyr AI) and industrials/tech (Veritiv), capitalizing on digitization, AI-driven efficiency, and supply chain resilience amid economic volatility.[1][2] Timing aligns with post-pandemic shifts toward scalable, tech-enabled services in mature markets, where CD&R's expertise amplifies growth in established firms rather than pure startups. Market forces like rising M&A in fragmented industries (e.g., financial services via Focus Financial) and sustainability demands favor its model, influencing the ecosystem by professionalizing operations in portfolio companies and fostering innovation through tech integrations.[1][4][6]
CD&R is poised for continued dominance in operational PE, with mega-deals like the $10.3B Sealed Air acquisition signaling appetite for large-scale transformations amid high interest rates and AI boom.[6] Trends like AI in healthcare/industrials and sustainable industrials will shape its path, potentially expanding tech portfolio amid $30B+ AUM. Its influence may evolve toward even deeper stewardship, blending profitability with ESG, reinforcing its legacy as a builder of enduring businesses—echoing the founders' vision of operational excellence driving timeless value.[3][6]
